Live News EARNINGS ARTICLE L impact Aug 04, 2026, 08:06 PM UTC

Niagen Bioscience Widens FY2026 Sales Guidance of $138.982M-$145.299M vs $141.072M Est

Niagen Bioscience (NASDAQ: NAGE ) widens FY2026 sales outlook from $138.982 million-$145.299 million to $138.982 million-$145.299 million vs $141.072 million estimate.

NAGE

SquawkNews Newsroom

Niagen Bioscience (NASDAQ: NAGE ) widens FY2026 sales outlook from $138.982 million-$145.299 million to $138.982 million-$145.299 million vs $141.072 million estimate.